Results 21 to 30 of about 66,208 (273)

Bronchiectasis as co morbidity with COPD or ILD: complex interactions and severe consequences

The Egyptian Journal of Bronchology, 2023
Background Bronchiectasis is a chronic pulmonary disease characterized by widened, malformed bronchi, with profuse expectoration and impaired quality of life. COPD and ILD are common co-morbidities with bronchiectasis. Methods The present study evaluated
Manal SH. Elhussini, Asmaa Mahmoud Mohammed, Hoda Assad Eid, Ahmed Gharib   +3 more
doaj   +1 more source

South African Thoracic Society position statement on the management of non-cystic fibrosis bronchiectasis in adults: 2023

African Journal of Thoracic and Critical Care Medicine, 2023
Background. Bronchiectasis is a chronic lung disorder that affects the lives of many South Africans. Post-tuberculosis (TB) bronchiectasis is an important complication of previous pulmonary TB and a common cause of bronchiectasis in South Africa (SA). No
A Goolam-Mahomed, S D Maasdorp, R Barnes, H Van Aswegen, A Lupton-Smith, B Allwood, G Calligaro, C Feldman, I Kalla   +8 more
doaj   +1 more source

Chronic Obstructive Pulmonary Disease Is Associated With Decreased Quality of Life in Bronchiectasis Patients: Findings From the KMBARC Registry

Frontiers in Medicine, 2021
Most studies have evaluated the impact of non-cystic fibrosis bronchiectasis (hereafter referred to as bronchiectasis) on quality of life (QoL) in patients with chronic obstructive pulmonary disease (COPD) using COPD cohorts.
Sang Hyuk Kim, Changhwan Kim, Ina Jeong, Seung Jun Lee, Tae Hyung Kim, Chang Youl Lee, Yeon-Mok Oh, Hyun Lee, Youlim Kim   +8 more
doaj   +1 more source

Pathophysiology of Bronchiectasis [PDF]

Seminars in Respiratory and Critical Care Medicine, 2021
AbstractBronchiectasis is a complex, heterogeneous disorder defined by both a radiological abnormality of permanent bronchial dilatation and a clinical syndrome. There are multiple underlying causes including severe infections, mycobacterial disease, autoimmune conditions, hypersensitivity disorders, and genetic conditions.
Keir, Holly R., Chalmers, James D.
openaire   +3 more sources

Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis.

, 2020
The objective of this study was to analyse lung function decline over time in bronchiectasis, along with the factors associated with it. Spirometry was measured every year in this observational, prospective study in 849 patients from the Spanish ...
Posadas, T, Feced-Olmos, L, Martinez-Garcia, M A, Rodriguez, J L, Olveira, C, Golpe, R, Garcia-Clemente, M, Zaldivar, E, Sibila, O, Rodriguez, J, Barreiro, E, Muriel, A, Giron, R, Maiz, L, Dobarganes, Y, de-la-Rosa, D, Villa, C, Prados, C, Oscullo, G   +18 more
core   +2 more sources

Polymicrobial airway bacterial communities in adult bronchiectasis patients [PDF]

, 2014
Background: Chronic airway infection contributes to the underlying pathogenesis of non-cystic fibrosis bronchiectasis (NCFBr). In contrast to other chronic airway infections, associated with COPD and CF bronchiectasis, where polymicrobial communities ...
Christopher J Stewart, Smith, Darren L., Jary, Hannah, Andrew Nelson, Perry, J. D. (John), Nelson, Andrew, Stewart, Christopher, Smith, Darren, Anthony De Soyza, Stephen P Cummings, Perry, A, John D Perry, Clare Lanyon, Purcell, Paul, Lanyon, Clare, Hannah Jary, Darren L Smith, Paul Purcell, de Soyza, Anthony, Perry, Audrey, Cummings, Stephen, Perry, John, Audrey Perry   +22 more
core   +1 more source

Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2018
Bronchiectasis are often encountered in clinical practice, and are characterized by abnormal airway dilatation and distortion associated with impaired mucociliary clearance and mucous plugging, which are frequently associated with recurrent infections ...
Ashley M. Egan, Jeremy M. Clain, Patricio Escalante   +2 more
doaj   +1 more source

Atorvastatin as a stable treatment in bronchiectasis:a randomised controlled trial [PDF]

, 2014
Background: Bronchiectasis is characterised by chronic cough, sputum production, and recurrent chest infections. Pathogenesis is poorly understood, but excess neutrophilic airway inflammation is seen.
John W Govan, Davidson, Donald J, Harley, Catherine, Donald J Davidson, Graham, Catriona, Rossi, Adriano G, Hill, Adam T, Hill, Adam T., Mandal, Pallavi, Catherine Doherty, Manjit K Sidhu, Sidhu, Manjit K., Chalmers, James D., Catherine Harley, Pallavi Mandal, James D Chalmers, Govan, John W, Doherty, Catherine, Chalmers, James D, Govan, John W., Sethi, Tariq, Rossi, Adriano G., Adam T Hill, Sidhu, Manjit K, Adriano G Rossi, Davidson, Donald J., Catriona Graham, Tariq Sethi   +27 more
core   +1 more source

Clinical features of patients with asthma, bronchiectasis, and combination of both conditions

Indian Journal of Respiratory Care, 2021
Background: Asthma and bronchiectasis are critical diseases for public health. In some patients, asthma and bronchiectasis exist together, and bronchiectasis negatively affects asthma control.
Fatih Uzer, Zehra Boztepe, Aykut Cilli
doaj   +1 more source

Bronchiectasis [PDF]

Tuberculosis and Respiratory Diseases, 2012
The frequency of diagnosing bronchiectasis is increasing around the world. Cystic fibrosis is the most common inherited cause of bronchiectasis, but there is increasing recognition of significant numbers of patients with bronchiectasis from various causes.
Kim, Changhwan, Kim, Dong-Gyu
openaire   +2 more sources